CAMP
CAMP4 Therapeutics CorporationNASDAQHealthcare$4.47+0.22%ClosedMarket Cap: $94.9M
As of 2026-04-06
Insider Statistics (Q2 2026)
Purchases
5
Sales
0
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri Apr 03 | Mandel-Brehm Josh | director, officer: Chief Executive Officer | Sell | 580,000 | $4.46 | 580,000 |
| Fri Apr 03 | Gold Kelly | officer: Chief Financial Officer | Sell | 215,000 | $4.46 | 215,000 |
| Fri Apr 03 | Maricich Yuri | officer: Chief Medical Officer | Sell | 215,000 | $4.46 | 215,000 |
| Fri Apr 03 | Tardiff Daniel | officer: Chief Scientific Officer | Sell | 170,000 | $4.46 | 170,000 |
| Fri Apr 03 | MacLean Michael F | director: | Sell | 0 | $0.00 | 0 |
| Fri Apr 03 | MacLean Michael F | director | Sell | 56,000 | $4.46 | 56,000 |
| Mon Dec 22 | Tardiff Daniel | officer: Chief Scientific Officer | Sell | 145,500 | $6.01 | 145,500 |
| Mon Dec 22 | Maricich Yuri | officer: Chief Medical Officer | Sell | 190,000 | $6.01 | 190,000 |
| Mon Dec 22 | Gold Kelly | officer: Chief Financial Officer | Sell | 190,000 | $6.01 | 190,000 |
| Mon Dec 22 | Mandel-Brehm Josh | director, officer: Chief Executive Officer | Sell | 425,000 | $6.01 | 425,000 |
| Fri Oct 10 | Tardiff Daniel | officer: Chief Scientific Officer | Sell | 22,289 | $9.08 | 0 |
| Fri Oct 10 | Tardiff Daniel | officer: Chief Scientific Officer | Sell | 5,000 | $3.53 | 0 |
| Fri Oct 10 | Tardiff Daniel | officer: Chief Scientific Officer | Sell | 25,000 | $3.86 | 0 |
| Mon Sep 15 | 5AM Partners VI, LLC | 10 percent owner | Buy | 2,941,176 | $1.53 | 2,941,176 |
| Mon Sep 15 | Schwab Andrew J. | director, 10 percent owner: | Sell | 2,941,176 | $1.53 | 2,941,176 |